Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tau phosphorylation is a critical post-translational modification of tau protein, which plays a key role in stabilizing microtubules in neurons. Abnormal hyperphosphorylation of tau leads to neurodegenerative diseases like Alzheimer's by disrupting microtubule stability and promoting tau aggregation. Drugs targeting tau phosphorylation aim to modulate this process to prevent or treat neurodegeneration.
Inhibiting tau kinases, enhancing tau phosphatase activity, or modulating other signaling pathways to reduce pathological tau phosphorylation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tau Phosphorylation (TauP).